Published online 8 July 2004
Nucleic Acids Research, Vol. 32 No. 12 © Oxford University Press 2004; all rights reserved
Human p32, interacts with B subunit of the CCAAT-binding factor, CBF/NF-Y, and inhibits CBF-mediated transcription activation in vitro
1 Department of Molecular Genetics and 2 Department of Molecular Pathology, M.D. Anderson Cancer Center and 3 Genes and Development Program, Graduate School of Biomedical Sciences, The University of Texas, Houston, TX 77030, USA
* To whom correspondence should be addressed. Tel: +1 713 792 8943; Fax: +1 713 794 4295; Email: smaity{at}mdanderson.org
Received April 23, 2004; Revised and Accepted June 18, 2004
To understand the role of the CCAAT-binding factor, CBF, in transcription, we developed a strategy to purify the heterotrimeric CBF complex from HeLa cell extracts using two successive immunoaffinity chromatography steps. Here we show that the p32 protein, previously identified as the ASF/SF2 splicing factor-associated protein, copurified with the CBF complex. Studies of proteinprotein interaction demonstrated that p32 interacts specifically with CBFB subunit and also associates with CBFDNA complex. Cellular localization by immunofluorescence staining revealed that p32 is present in the cell throughout the cytosol and nucleus, whereas CBF is present primarily in the nucleus. A portion of the p32 colocalizes with CBF-B in the nucleus. Interestingly, reconstitution of p32 in an in vitro transcription reaction demonstrated that p32 specifically inhibits CBF-mediated transcription activation. Altogether, our study identified p32 as a novel and specific corepressor of CBF-mediated transcription activation in vitro.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Huang, J. Chi, F. B. Berry, T. K. Footz, M. W. Sharp, and M. A. Walter Human p32 Is a Novel FOXC1-Interacting Protein That Regulates FOXC1 Transcriptional Activity in Ocular Cells Invest. Ophthalmol. Vis. Sci., December 1, 2008; 49(12): 5243 - 5249. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Mertz, R. Kobayashi, and J. P. Dudley ALY Is a Common Coactivator of RUNX1 and c-Myb on the Type B Leukemogenic Virus Enhancer J. Virol., April 1, 2007; 81(7): 3503 - 3513. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Hu, J.-F. Lu, R. Luo, S. Sen, and S. N. Maity Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycle Nucleic Acids Res., December 4, 2006; 34(21): 6272 - 6285. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Navarro, P. Cau, and N. Levy Molecular bases of progeroid syndromes Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R151 - R161. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ohrmalm and G. Akusjarvi Cellular Splicing and Transcription Regulatory Protein p32 Represses Adenovirus Major Late Transcription and Causes Hyperphosphorylation of RNA Polymerase II. J. Virol., May 1, 2006; 80(10): 5010 - 5020. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Berro, K. Kehn, C. de la Fuente, A. Pumfery, R. Adair, J. Wade, A. M. Colberg-Poley, J. Hiscott, and F. Kashanchi Acetylated Tat Regulates Human Immunodeficiency Virus Type 1 Splicing through Its Interaction with the Splicing Regulator p32. J. Virol., April 1, 2006; 80(7): 3189 - 3204. [Abstract] [Full Text] [PDF] |
||||



